B O O K - American College of Rheumatology

monday
Upon completion of this session, participants should be able to:
• review the clinical manifestations of inflammatory myopathies
including important extra-muscle manifestations
• discuss diagnostic pearls for the evaluation of someone
suspected of having an inflammatory myopathy
• discuss the treatment paradigm for inflammatory myopathies
B208
Ankylosing Spondylitis: 2010 Update (012) PS
Speaker: Desiree M. Van Der Heijde, MD, PhD; Leiden University
Medical Center; Meerssen, Netherlands
Upon completion of this session, participants should be able to:
• discuss the natural history of ankylosing spondylitis and its
early diagnosis
• describe clinical and radiographic outcome measures used in
ankylosing spondylitis trials
• summarize available guidelines in the management of
ankylosing spondylitis
• review the scientific data on biologic agents as possible
disease modifying agents in the treatment of ankylosing
spondylitis
B209
Cutaneous Vasculitis (013)
Speaker: Nicole Fett, MD; Perelman Center for Advanced
Medicine; Philadelphia, PA
Upon completion of this session, participants should be able to:
• distinguish the clinical features of small and medium-sized
vasculitides that involve the skin
• gain insight into the pathological features of cutaneous
vasculitis, which lead directly to clinical disease observable on
the skin
• identify vasculitis mimickers with cutaneous involvement
• develop a rational approach to the evaluation and
management of cutaneous vasculitis
B301
Osteoporosis: Novel Treatments (014) PS
Speaker: Michael J. Maricic, MD; Catalina Pointe Rheumatology;
Tucson, AZ
Upon completion of this session, participants should be able to:
• review bone physiology and immunology emphasizing
potential areas amenable to intervention
• discuss current therapies for osteoporosis and their limitations
• identify newer treatments available and therapies just over
the horizon for osteoporosis
B302
Pain: Evaluation and Treatment of Back Pain (015) PM
Speaker: David G. Borenstein, MD; Arthritis & Rheumatism
Association; Washington, DC
Upon completion of this session, participants should be able to:
• determine the appropriate use of diagnostic tests in the
evaluation of low back pain
• review effective therapies for low back pain
• identify the types of exercises that prevent and treat low back
pain
B303
Pediatrics: Juvenile Idiopathic Arthritis for Adult
Rheumatologists (016) P
Speaker: AnneMarie C. Brescia, MD; DuPont Hospital for
Children; Wilmington, DE
Upon completion of this session, participants should be able to:
• review the International League of Associations for
Rheumatology classification for juvenile rheumatoid arthritis/
juvenile idiopathic arthritis
• discuss current therapeutic strategies for juvenile rheumatoid
arthritis/juvenile idiopathic arthritis
• describe the role of interleukin-1 in the pathogenesis
of systemic onset juvenile rheumatoid arthritis/juvenile
idiopathic arthritis
B304
Pregnancy in Rheumatic Diseases (017)
Speaker: Megan E.B. Clowse, MD, MPH; Duke University Medical
Center; Durham, NC
Upon completion of this session, participants should be able to:
• discuss the effects of pregnancy on the activity of rheumatic
diseases
• describe the challenging management issues unique to
pregnancy
B305
Rheumatoid Arthritis: Early Rheumatoid Arthritis
(018) PS
Speaker: Johanna Hazes, MD, PhD; Erasmus Medical Centre
Rotterdam; Rotterdam, Netherlands
Upon completion of this session, participants should be able to:
• identify the clinical syndrome of rheumatoid arthritis early in
its course
• determine which modalities are of use in diagnosis and
determining prognosis
• evaluate which therapeutic regimens yield the best long-term
outcomes
B210
Systemic Lupus Erythematosus: Difficult to Treat
Systemic Lupus Erythematosus (019) P
Speaker: Elena M. Massarotti, MD; Brigham and Women’s
Hospital; Boston, MA
Upon completion of this session, participants should be able to:
• utilize laboratory testing in the management of patients with
systemic lupus erythematosus
• determine the most relevant and beneficial therapeutic
approach
• identify appropriate assessment tools for use in management
and prognosis
B306
Vitamin D and Bone Health (020)
Speaker: Karen E. Hansen, MD; University of Wisconsin;
Madison, WI
Upon completion of this session, participants should be able to:
• identify the metabolic consequences of vitamin D deficiency
36
2010 Program Book